Macrophage Plasticity and Polarization Are Altered in the Experimental Model of Multiple Sclerosis

Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous system. MS is characterized by infiltrations of leukocytes such as T and B lymphocytes and macrophages. Macrophages have been identified as major effectors of inflammation and demyelination in both MS and its...

Full description

Bibliographic Details
Published in:	Biomolecules
Main Authors:	Alessandro Leuti, Emanuela Talamonti, Antonietta Gentile, Marta Tiberi, Alessandro Matteocci, Diego Fresegna, Diego Centonze, Valerio Chiurchiù
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Subjects:	multiple sclerosis EAE macrophages cytokines chemokines toll-like receptors
Online Access:	https://www.mdpi.com/2218-273X/11/6/837

Similar Items

CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by <it>in vivo </it>axial diffusivity
by: Cruz-Orengo Lillian, et al.
Published: (2011-12-01)

Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis
by: Gabriele Musumeci, et al.
Published: (2011-09-01)

Metabolomics as a promising tool for improving understanding of multiple sclerosis: A review of recent advances
by: Zhicheng Liu, et al.
Published: (2022-08-01)

Central Nervous System Proteomics in Animal Model of Multiple Sclerosis Revealed Down-Regulation of Mithochondrial Proteins
by: Abolhassan Shahzadeh Fazeli, et al.
Published: (2009-01-01)

The presence of cerebellar B cell aggregates is associated with a specific chemokine profile in the cerebrospinal fluid in a mouse model of multiple sclerosis
by: Verena Schropp, et al.
Published: (2023-01-01)

Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis
by: Antonietta Gentile, et al.
Published: (2019-09-01)

Fc multimers effectively treat murine models of multiple sclerosis
by: Jin Wang, et al.
Published: (2023-08-01)

Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis
by: Luana Gilio, et al.
Published: (2024-08-01)

Antigen B modulates anti‐inflammatory cytokines in the EAE model of multiple sclerosis
by: Aliakbar Mariki, et al.
Published: (2023-02-01)

The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?
by: Hannah M. Kohl, et al.
Published: (2020-08-01)

Chemokines as therapeutic targets for multiple sclerosis: a spatial and chronological perspective
by: Nagisa Nakata Arimitsu, et al.
Published: (2025-03-01)

FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models
by: Ranjithkumar Rajendran, et al.
Published: (2021-04-01)

An Overview of Peptide-Based Molecules as Potential Drug Candidates for Multiple Sclerosis
by: Annarita Del Gatto, et al.
Published: (2021-08-01)

Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis
by: Thomas eQuinn, et al.
Published: (2011-08-01)

Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis
by: Marjan Gharagozloo, et al.
Published: (2022-11-01)

[18F]FSPG-PET reveals increased cystine/glutamate antiporter (xc-) activity in a mouse model of multiple sclerosis
by: Aileen Hoehne, et al.
Published: (2018-02-01)

Possible Correlation between Cholinergic System Alterations and Neuro/Inflammation in Multiple Sclerosis
by: Valentina Gatta, et al.
Published: (2020-06-01)

Liposome-Assisted Drug Delivery in the Treatment of Multiple Sclerosis
by: Giuliana Greco, et al.
Published: (2024-10-01)

Effectiveness of exercise interventions in animal models of multiple sclerosis
by: Abdolhossein Parnow, et al.
Published: (2023-03-01)

B cell depletion modulates glial responses and enhances blood vessel integrity in a model of multiple sclerosis
by: Julie J. Ahn, et al.
Published: (2023-10-01)

Developing a minimally invasive gene therapy for multiple sclerosis
by: Paul J.H. Nijhuis, et al.
Published: (2025-09-01)

Resveratrol Neuroprotection in a Chronic Mouse Model of Multiple Sclerosis
by: Zoe eFonseca-Kelly, et al.
Published: (2012-05-01)

Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice
by: Amin Daei Sorkhabi, et al.
Published: (2023-11-01)

Positive allosteric modulation of AMPA receptors via PF4778574 leads to reduced demyelination and clinical disability in experimental models of multiple sclerosis
by: Mustafa Sindi, et al.
Published: (2025-03-01)

Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis
by: Antonietta eGentile, et al.
Published: (2015-06-01)

Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis
by: Silvia Rossi, et al.
Published: (2009-10-01)

Early derangement of axonal mitochondria occurs in a mouse model of progressive but not relapsing-remitting multiple sclerosis
by: Daniela Buonvicino, et al.
Published: (2023-03-01)

Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis
by: Kathrin Bail, et al.
Published: (2017-07-01)

The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
by: Trevor O. Kirby, et al.
Published: (2018-08-01)

Gut microbiome-modulated dietary strategies in EAE and multiple sclerosis
by: Kristina Hoffman, et al.
Published: (2023-03-01)

Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions
by: Alessandra Musella, et al.
Published: (2018-08-01)

The role of chemokines in shaping the balance between CD4+ T cell subsets and its therapeutic implications in autoimmune and cancer diseases
by: Nathan eKarin, et al.
Published: (2015-11-01)

Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis
by: Alessandra Musella, et al.
Published: (2020-05-01)

An expanded polyglutamine in ATAXIN1 results in a loss-of-function that exacerbates severity of Multiple Sclerosis in an EAE mouse model
by: Gourango Talukdar, et al.
Published: (2025-04-01)

Osteopontin expression and the effect of anti-VLA-4 mAb treatment in experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis
by: Grażyna Pyka-Fościak, et al.
Published: (2023-07-01)

The role of interleukin 22 in multiple sclerosis and its association with c-Maf and AHR
by: Michal Konrad Zarobkiewicz, et al.
Published: (2019-09-01)

Diffusion Kurtosis Imaging maps neural damage in the EAE model of multiple sclerosis
by: Andrey Chuhutin, et al.
Published: (2020-03-01)

NMDA Receptor Antagonist Memantine Ameliorates Experimental Autoimmune Encephalomyelitis in Aged Rats
by: Biljana Bufan, et al.
Published: (2024-03-01)

Gene Expression Analysis of Astrocyte and Microglia Endocannabinoid Signaling during Autoimmune Demyelination
by: Álvaro Moreno-García, et al.
Published: (2020-08-01)

Developmental ablation of mature oligodendrocytes exacerbates adult CNS demyelination
by: Ahdeah Pajoohesh-Ganji, et al.
Published: (2020-08-01)